NAFDAC Urges Pharma Firms to Invest in Vaccine Production for Health Security
The Director General of NAFDAC, Prof. Mojisola Adeyeye, called on pharmaceutical companies in Nigeria to invest in vaccine production during a lecture at a NAPharm event in Lagos. She emphasized the importance of local vaccine manufacturing to avoid being unprepared for future health crises like COVID-19.
Adeyeye highlighted the need for regulatory improvements and mentioned NAFDAC's plans to separate vaccine regulation from other products. The move aims to boost efficiency and align with global standards, ultimately leading to the local production of vaccines in Nigeria.
Plus234Feed summary based on reporting from Leadership Newspaper. Read the original report below.
Read full article
Continue on Leadership Newspaper
Get the week in one email
Top stories, NPFL results, the naira — every Friday morning. Free, one email a week.
Related Stories
Nigeria Explores Innovative Tech to Boost Local Drug Production
Nigeria Seeks N150bn for Vaccine Funding in Health Sector Boost
Nigerian Health Minister Explains Why Country Cannot Produce Vaccines Locally
NBRDA Partners for Local Production of HIV Drugs in Nigeria
Nigeria and Russia Discuss Vaccine and Livestock Partnerships
Nigeria, EU, and France Collaborate to Boost Pharmaceutical Manufacturing in $10.2M Project
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
